• Company
• Peter Trang will head Business Operations at Takeda Korea
• by Whang, byung-woo Sep 20, 2024 05:51am

• Company
• Ipsen Korea appoints Yang mi-sun as new CEO
• by Eo, Yun-Ho Sep 20, 2024 05:51am

• Company
• Inventage Lab to codevelop a long-acting injectable with BI
• by Lee, Seok-Jun Sep 20, 2024 05:51am

• Policy
• Cushing’s syndrome drug Isturisa is approved in Korea
• by Lee, Hye-Kyung Sep 20, 2024 05:51am

• Company
• Samsung Bioepis recruits Lina Choi as new global head
• by Nho, Byung Chul Sep 19, 2024 05:48am

• Opinion
• [Reporter’s View] The new drug approval fee hike
• by Lee, Hye-Kyung Sep 19, 2024 05:48am

• Policy
• MFDS approves Hemgenix for Hemophilia B in Korea
• by Lee, Hye-Kyung Sep 19, 2024 05:48am

• Company
• Will Columvi be reviewed for reimb by CDDC in OCT?
• by Eo, Yun-Ho Sep 19, 2024 05:48am

• Company
• Reimb for orphan drug 'Welireg' for cancer has been denied
• by Eo, Yun-Ho Sep 19, 2024 05:48am

• Opinion
• [Reporter’s View] Benefits of the U.S. Biosecure Act
• by Son, Hyung Min Sep 13, 2024 05:50am